EUVIMEDEUVIMED entdecken
Open Access

Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning

Mulki Mehari iD, Gayathri Warrier iD, Abraham Dada iD, Aymen Kabir iD, Aden P Haskell-Mendoza iD, Arushi Tripathy iD, Rohan Jha iD, Edwin Nieblas-Bedolla iD, Joshua D Jackson, Ariel T Gonzalez iD, Ellery H Reason iD, Ann Marie Flusche iD und 16 weitere

Science Advances · 06.06.2025 · 11 (23)

DOI: 10.1126/sciadv.adt5708 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.06.2025. Verfasst von Mulki Mehari und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of California, San Francisco, San Francisco, CA 94143, USA. Hauptthemen laut MEDLINE: Glioma, Supervised Machine Learning, Clinical Trials as Topic, Brain Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic clinical trial enrollment does not match glioma incidence across demographics. Traditional statistical methods have identified independent predictors of trial enrollment; however, our understanding of the interactions between these factors remains limited. To test the interactive effects of demographic, socioeconomic, and oncologic variables on trial enrollment, we designed boosted neural networks (BNNs) for all glioma patients ( n = 1042), women ( n = 445, 42.7%), and minorities ( n = 151, 14.5%) and externally validated these models [whole cohort, n = 230; women, n = 89 (38.7%); minority, n = 66 (28.7%)]. For the whole-cohort BNN, the most influential variables on enrollment were oncologic variables, including KPS [total effect (TE), 0.327], chemotherapy (TE, 0.326), tumor location (TE, 0.322), and seizures (TE, 0.239). The women-only BNN exhibited a similar trend. Conversely, for the minority-only BNN, socioeconomic variables [insurance status (TE, 0.213), occupation classification (TE, 0.204), and employment status (TE, 0.150)] were most influential. These results may help prioritize patient-specific initiatives to increase accrual.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaSupervised Machine LearningClinical Trials as TopicBrain NeoplasmsPatient SelectionHumansFemaleMaleAdultMiddle AgedNeoplasm GradingAgedSocioeconomic Factors

Autor:innen und Institutionen

  • Department of Neurosurgery, University of California, San Francisco, San Francisco, CA 94143, USA.
  • Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Neurosurgery, Michigan Medicine, Ann Arbor, MI 48109, USA.
  • Harvard Medical School, Boston, MA 02115, USA.
  • Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  • Preston Robert Tisch Brain Tumor Center, Department of Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA.

ORCID-Profile: Mulki Mehari, Gayathri Warrier, Abraham Dada, Aymen Kabir, Aden P Haskell-Mendoza, Arushi Tripathy, Rohan Jha, Edwin Nieblas-Bedolla, Ariel T Gonzalez, Ellery H Reason, Ann Marie Flusche, Sheantel Reihl, Tara Dalton, Vardhaan S Ambati, Annick Desjardins, Saritha Krishna, Susan Chang, Alyx Porter, Todd Hollon, Ugonma N Chukwueke, Kimberly Badal, Annette M Molinaro, Shawn L Hervey-Jumper

Förderung

  • NINDS NIH HHS

Zitieren

APA

Mehari, M., Warrier, G., Dada, A., Kabir, A., Haskell-Mendoza, A. P., Tripathy, A., Jha, R., Nieblas-Bedolla, E., Jackson, J. D., Gonzalez, A. T., Reason, E. H., Flusche, A. M., Reihl, S., Dalton, T., Negussie, M., Gonzales, C. N., Ambati, V. S., Desjardins, A., Daniel, A. G. S., …, & Hervey-Jumper, S. L. (2025). Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning. Science Advances, 11(23). https://doi.org/10.1126/sciadv.adt5708

Vancouver

Mehari M, Warrier G, Dada A, Kabir A, Haskell-Mendoza AP, Tripathy A, et al. Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning. Science Advances. 2025;11(23). doi:10.1126/sciadv.adt5708

BibTeX
@article{Mehari2025,
  author = {Mehari, Mulki and Warrier, Gayathri and Dada, Abraham and Kabir, Aymen and Haskell-Mendoza, Aden P and Tripathy, Arushi and Jha, Rohan and Nieblas-Bedolla, Edwin and Jackson, Joshua D and Gonzalez, Ariel T and Reason, Ellery H and Flusche, Ann Marie and Reihl, Sheantel and Dalton, Tara and Negussie, Mikias and Gonzales, Cesar Nava and Ambati, Vardhaan S and Desjardins, Annick and Daniel, Andy G S and Krishna, Saritha and Chang, Susan and Porter, Alyx and Fecci, Peter E and Hollon, Todd and Chukwueke, Ugonma N and Badal, Kimberly and Molinaro, Annette M and Hervey-Jumper, Shawn L},
  title = {Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learning},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {23},
  doi = {10.1126/sciadv.adt5708}
}
Kostenlos starten →